Craft

Verseau Therapeutics

Total Funding

$50 M

Verseau Therapeutics Summary

Company Summary

Overview
Verseau Therapeutics is a company that develops macrophage checkpoint modulators designed to benefit patients with cancer, immune and inflammatory diseases. Its modulators identify novel targets and develop therapies that shift macrophages between immune activators and silencers in disease, enabling physicians to benefit patients from immunotherapy.
Type
Private
Status
Active
Founded
2017
HQ
Bedford, MA, US | view all locations
Website
https://www.verseautx.com/
Cybersecurity rating
Sectors

Key People

  • John Edwards

    John Edwards, Chief Executive Officer

    • Igor Feldman

      Igor Feldman, Co-Founder and Chief Analytics Officer

      • Tatiana Novobrantseva

        Tatiana Novobrantseva, Co-Founder and Chief Scientific Officer

        • Tim Smith

          Tim Smith, Chief Business Officer

        LocationsView all

        1 location detected

        • Bedford, MA HQ

          United States

          47 Wiggins Ave

        Footer menu